CLINICAL STUDIES ON AB-206 IN URINARY TRACT INFECTION
1978 Volume 26 Issue Supplement4 Pages 218-223
Details
1978 Volume 26 Issue Supplement4 Pages 218-223
Clinical studies were made on AB-206 in 55 patients suffering from urinary tract infection, but in only 3 patients administration of AB-206 had to be discontinued due to side effect.
AB-206 was administrated orally at the dosage of 1 or 1. 5 g for 7 days.
Results were excellent in 23 (44. 2%), good in 9 (17. 3%), fair in 7 (13. 5%) and poor in 13 (25.0%) of the 52 cases.
Bacteriological results were eradicated in 26 (50. 0%), decreased in 12 (23. 1%). and unchanged in 14 (26. 9%) of the 52 strains.
As for side effects, gastro-intestinal symptoms, heartburn and obdormition in the extremities or the mouth were observed in 9 cases of this series, in 3 cases of them AB-206 was discontinued.
